JP7366711B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP7366711B2 JP7366711B2 JP2019213511A JP2019213511A JP7366711B2 JP 7366711 B2 JP7366711 B2 JP 7366711B2 JP 2019213511 A JP2019213511 A JP 2019213511A JP 2019213511 A JP2019213511 A JP 2019213511A JP 7366711 B2 JP7366711 B2 JP 7366711B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- oral composition
- component
- caffeine
- sweetness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 38
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 70
- 235000013305 food Nutrition 0.000 claims description 42
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 35
- 229960001948 caffeine Drugs 0.000 claims description 35
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 35
- 239000007787 solid Substances 0.000 claims description 25
- 150000002016 disaccharides Chemical class 0.000 claims description 16
- 150000005846 sugar alcohols Chemical class 0.000 claims description 16
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 claims description 11
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 claims description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 7
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 6
- 239000004386 Erythritol Substances 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- 239000000845 maltitol Substances 0.000 claims description 6
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 6
- 235000010449 maltitol Nutrition 0.000 claims description 6
- 229940035436 maltitol Drugs 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 229960002160 maltose Drugs 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 229960001855 mannitol Drugs 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000011156 evaluation Methods 0.000 description 42
- 230000001953 sensory effect Effects 0.000 description 33
- 238000000034 method Methods 0.000 description 29
- 235000013361 beverage Nutrition 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000000523 sample Substances 0.000 description 15
- 235000015110 jellies Nutrition 0.000 description 13
- 239000008274 jelly Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000005469 granulation Methods 0.000 description 11
- 230000003179 granulation Effects 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 235000019615 sensations Nutrition 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 229950008138 carmellose Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical group C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 235000021055 solid food Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 235000021557 concentrated beverage Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- -1 sucrose fatty acid ester Chemical class 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Description
本発明は、経口組成物に関する。 TECHNICAL FIELD This invention relates to oral compositions.
糖アルコール及び二糖は甘味のキレがよく、単糖に比べて甘味が穏やかでありながらも、味の厚み(ボディ感)をもたらし、製造物性に優れていることから、甘味料や賦形剤として使用されている(特許文献1、2)。 Sugar alcohols and disaccharides have a sharp sweetness and are milder in sweetness than monosaccharides, yet they provide a richer taste (body) and have excellent manufacturing properties, so they are used as sweeteners and excipients. (Patent Documents 1 and 2).
一方、カフェインは、脂質エネルギー代謝や運動機能の向上等の生理効果を有することが知られており、近年カフェインを強化した飲食品の需要が拡大している。 On the other hand, caffeine is known to have physiological effects such as improving lipid energy metabolism and motor function, and the demand for food and drinks enriched with caffeine has increased in recent years.
本発明者らは、機能性素材としてカフェインを含有する飲食品を開発すべく、カフェインを含有する飲食品に糖アルコール及び/又は二糖を含有させたところ、ボディ感が低下するだけでなく、甘味のキレも悪化するという課題が存在することを見出した。
本発明の課題は、カフェインを含有しながらも、ボディ感が保たれ、甘味のキレの良好な経口組成物を提供することにある。
In order to develop food and drink products containing caffeine as a functional ingredient, the present inventors added sugar alcohols and/or disaccharides to food and drink products containing caffeine. It has been found that there is a problem that the sharpness of the sweetness is also worsened.
An object of the present invention is to provide an oral composition that maintains a body feel and has a good sharp sweetness even though it contains caffeine.
本発明者らは、上記課題に鑑み、鋭意研究を重ねた結果、糖アルコール及び/又は二糖と、カフェインを含有する経口組成物に、カフェインに対して特定のポリフェノールを特定の量比で含有させることで、糖アルコール及び/又は二糖と、カフェインを含有しながらも、ボディ感が保たれ、甘味のキレの良好な経口組成物が得られることを見出した。 In view of the above-mentioned problems, the present inventors have conducted intensive research and found that a specific polyphenol is added to an oral composition containing a sugar alcohol and/or a disaccharide, and caffeine in a specific amount ratio. It has been found that by containing the sugar alcohol and/or disaccharide and caffeine, an oral composition that maintains body feeling and has a good sharp sweetness can be obtained.
すなわち、本発明は、次の成分(A)、(B)及び(C);
(A)糖アルコール及び二糖から選択される少なくとも1種
固形分中に20~95質量%
(B)カフェイン 固形分中に0.01~1.0質量%、及び
(C)アストラガリン
を含有し、
成分(B)と成分(C)との質量比[(C)/(B)]が0.01~1である、
経口組成物を提供するものである。
That is, the present invention comprises the following components (A), (B) and (C);
(A) At least one selected from sugar alcohols and disaccharides
20-95% by mass in solid content
(B) Contains 0.01 to 1.0% by mass of caffeine in solid content, and (C) Astragalin,
The mass ratio [(C)/(B)] of component (B) and component (C) is 0.01 to 1;
Oral compositions are provided.
本発明によれば、糖アルコール及び/又は二糖と、カフェインを含有しながらも、ボディ感が保たれ、甘味のキレの良好な経口組成物を提供することができる。 According to the present invention, it is possible to provide an oral composition that maintains a body feel and has a good sharp sweetness even though it contains a sugar alcohol and/or a disaccharide and caffeine.
本明細書において「経口組成物」とは、経口摂取に供される製品をいう。経口組成物の製品形態としては、常温(20℃±15℃)において固形でも、液状でもよく、特に限定されない。液状の場合、濃縮液状、ゲル状、ゼリー状、スラリー状のいずれの形態であっても構わない。濃縮液状である場合、その固形分濃度はRTD(レディ・トゥ・ドリンク)よりも高濃度であれば適宜選択可能であり、特に限定されない。固形としては、例えば、粉末状、顆粒状、錠状、棒状、板状、ブロック状等を挙げることができる。 As used herein, "oral composition" refers to a product that is intended for oral ingestion. The product form of the oral composition is not particularly limited and may be solid or liquid at room temperature (20°C±15°C). In the case of liquid, it may be in any form such as concentrated liquid, gel, jelly, or slurry. In the case of a concentrated liquid, the solid content concentration can be appropriately selected as long as it is higher than RTD (ready-to-drink), and is not particularly limited. Examples of solids include powders, granules, tablets, rods, plates, and blocks.
本発明の経口組成物は、固形分が2.5%以上が好ましく、2.7%以上がより好ましく、3%以上が更に好ましい。より具体的には、経口組成物が液状である場合、経口組成物中の固形分量は通常2.5質量%以上、好ましくは2.7質量%以上、より好ましくは2.9質量%以上、更に好ましくは3.0質量%以上であって、好ましくは20質量%以下、より好ましくは18質量%以下、更に好ましくは15質量%以下、殊更に好ましくは10質量%以下である。また、経口組成物が固形である場合、経口組成物中の固形分量は通常80質量%以上、好ましくは90質量%以上、より好ましくは93質量%以上、更に好ましくは95質量%以上である。なお、固形である場合の固形分量の上限は特に限定されず、100質量%であってもよい。ここで、本明細書において「固形分量」とは、試料を105℃の電気恒温乾燥機で3時間乾燥して揮発物質を除いた残分の質量をいう。中でも、経口組成物の製品形態としては、固形、濃縮液状が好ましく、固形が更に好ましい。固形の中では、粉末状、顆粒状が好ましい。 The solid content of the oral composition of the present invention is preferably 2.5% or more, more preferably 2.7% or more, and even more preferably 3% or more. More specifically, when the oral composition is liquid, the solid content in the oral composition is usually 2.5% by mass or more, preferably 2.7% by mass or more, more preferably 2.9% by mass or more, More preferably, it is 3.0% by mass or more, preferably 20% by mass or less, more preferably 18% by mass or less, still more preferably 15% by mass or less, particularly preferably 10% by mass or less. Further, when the oral composition is solid, the solid content in the oral composition is usually 80% by mass or more, preferably 90% by mass or more, more preferably 93% by mass or more, and still more preferably 95% by mass or more. In addition, the upper limit of the solid content in the case of solid is not particularly limited, and may be 100% by mass. Here, in this specification, "solid content" refers to the mass of the residue after drying the sample in an electric constant temperature dryer at 105° C. for 3 hours and removing volatile substances. Among these, the product form of the oral composition is preferably solid or concentrated liquid, and solid is more preferred. Among solid forms, powder and granule forms are preferred.
本発明の経口組成物は、成分(A)として糖アルコール及び二糖から選択される少なくとも1種を含有する。
糖アルコールとしては、例えば、エリスリトール、キシリトール、マンニトール、ソルビトール、マルチトール、イソマルチトール、ラクチトール、パラチニット等を挙げることができる。糖アルコールは、1種又は2種以上を使用することができる。中でも、糖アルコールとしては、ボディ感の保持、甘味のキレ改善の観点から、キシリトール、エリスリトール、マルチトール及びマンニトールから選択される1種又は2種以上が好ましく、キシリトール、エリスリトール及びマルチトールから選択される1種又は2種以上が更に好ましい。
The oral composition of the present invention contains at least one selected from sugar alcohols and disaccharides as component (A).
Examples of sugar alcohols include erythritol, xylitol, mannitol, sorbitol, maltitol, isomaltitol, lactitol, palatinit, and the like. One type or two or more types of sugar alcohols can be used. Among these, the sugar alcohol is preferably one or more selected from xylitol, erythritol, maltitol, and mannitol, from the viewpoint of maintaining the body feeling and improving the sharpness of sweetness. More preferably, one or more of the following are preferred.
二糖としては、例えば、スクロース、マルトース、ラクトース、パラチノース、セロビオース、トレハロース等が挙げられる。二糖は、1種又は2種以上を使用することができる。中でも、二糖としては、ボディ感の保持、甘味のキレ改善の観点から、マルトース、パラチノース及びラクトースから選択される1種又は2種以上が好ましく、マルトース及びパラチノースから選択される少なくとも1種がより好ましく、マルトースが更に好ましい。 Examples of disaccharides include sucrose, maltose, lactose, palatinose, cellobiose, and trehalose. One type or two or more types of disaccharides can be used. Among these, the disaccharide is preferably one or more selected from maltose, palatinose, and lactose, and more preferably at least one selected from maltose and palatinose, from the viewpoint of maintaining body feeling and improving sharpness of sweetness. Preferably, maltose is more preferable.
成分(A)としては、キシリトール、エリスリトール、マルチトール、マンニトール、マルトース、パラチノース及びラクトースから選択される1種又は2種以上が好ましく、キシリトール、エリスリトール、マルチトール、マルトース及びパラチノースから選択される1種又は2種以上がより好ましく、キシリトール、エリスリトール、マルチトール及びマルトースから選択される1種又は2種以上が更に好ましい。 Component (A) is preferably one or more selected from xylitol, erythritol, maltitol, mannitol, maltose, palatinose, and lactose, and one selected from xylitol, erythritol, maltitol, maltose, and palatinose. Or two or more types are more preferable, and one or more types selected from xylitol, erythritol, maltitol, and maltose are even more preferable.
本発明の経口組成物中の成分(A)の含有量は、固形分中に20~95質量%であるが、ボディ感の保持の観点から、22質量%以上が好ましく、25質量%以上がより好ましく、28質量%以上が更に好ましく、また甘味のキレ改善の観点から、90質量%以下が好ましく、80質量%以下がより好ましく、60質量%以下が更に好ましい。かかる成分(A)の含有量の範囲としては、本発明の経口組成物の固形分中に、好ましくは22~90質量%であり、より好ましくは25~80質量%であり、更に好ましくは28~60質量%である。 The content of component (A) in the oral composition of the present invention is 20 to 95% by mass in the solid content, but from the viewpoint of maintaining body feel, it is preferably 22% by mass or more, and 25% by mass or more. The content is more preferably 28% by mass or more, and from the viewpoint of improving the sharpness of sweetness, the content is preferably 90% by mass or less, more preferably 80% by mass or less, and even more preferably 60% by mass or less. The content of component (A) in the solid content of the oral composition of the present invention is preferably 22 to 90% by mass, more preferably 25 to 80% by mass, and even more preferably 28% by mass. ~60% by mass.
本発明の経口組成物は、成分(B)としてカフェインを含有する。成分(B)は、原料に由来するものでも、新たに加えられたものでもよい。また、成分(B)は、飲食品の分野において通常使用されているものであれば由来は特に限定されず、例えば、化学合成品でも、天然由来品でもよい。 The oral composition of the present invention contains caffeine as component (B). Component (B) may be derived from raw materials or may be newly added. In addition, the origin of component (B) is not particularly limited as long as it is commonly used in the field of food and beverages, and for example, it may be a chemically synthesized product or a naturally derived product.
本発明の経口組成物中の成分(B)の含有量は、固形分中に0.01~1.0質量%であるが、生理効果の観点から、0.02質量%以上が好ましく、0.03質量%以上がより好ましく、0.04質量%以上が更に好ましく、またカフェイン由来の苦味抑制の観点から、0.8質量%以下が好ましく、0.6質量%以下がより好ましく、0.3質量%以下が更に好ましい。成分(B)の含有量の範囲としては、本発明の経口組成物の固形分中に、好ましくは0.02~0.8質量%であり、より好ましくは0.03~0.6質量%であり、更に好ましくは0.04~0.3質量%である。なお、成分(B)が水和物の形態である場合、成分(B)の含有量は無水物に換算した値とする。また、成分(B)の含有量は、通常知られている測定法のうち測定試料の状況に適した分析法により測定することが可能であり、例えば、液体クロマトグラフィで分析することが可能である。具体的には、後掲の実施例に記載の方法が挙げられる。なお、測定の際には装置の検出域に適合させるため、試料を凍結乾燥したり、装置の分離能に適合させるため試料中の夾雑物を除去したりする等、必要に応じて適宜処理を施してもよい。 The content of component (B) in the oral composition of the present invention is 0.01 to 1.0% by mass in the solid content, but from the viewpoint of physiological effects, it is preferably 0.02% by mass or more, and 0.02% by mass or more. More preferably 0.03% by mass or more, still more preferably 0.04% by mass or more, and from the viewpoint of suppressing bitterness derived from caffeine, 0.8% by mass or less is preferred, more preferably 0.6% by mass or less, 0. More preferably, the content is .3% by mass or less. The content range of component (B) is preferably 0.02 to 0.8% by mass, more preferably 0.03 to 0.6% by mass in the solid content of the oral composition of the present invention. and more preferably 0.04 to 0.3% by mass. In addition, when component (B) is in the form of a hydrate, let the content of component (B) be the value converted into an anhydride. In addition, the content of component (B) can be measured by an analytical method suitable for the situation of the measurement sample among commonly known measuring methods; for example, it can be analyzed by liquid chromatography. . Specifically, the method described in Examples below may be mentioned. In addition, during measurement, appropriate processing is performed as necessary, such as freeze-drying the sample to match the detection range of the device, or removing impurities from the sample to match the separation capability of the device. It may be applied.
本発明の経口組成物は、成分(C)としてアストラガリンを含有する。ここで、本明細書において「アストラガリン」とは、ケンフェロールの3位にグルコースが結合した化合物である。成分(C)は、原料に由来するものでも、新たに加えられたものでもよい。また、成分(C)は、飲食品の分野において通常使用されているものであれば由来は特に限定されず、例えば、化学合成品でも、アストラガリンを含有する植物から抽出したものでもよい。 The oral composition of the present invention contains astragalin as component (C). Here, "astragalin" as used herein is a compound in which glucose is bound to the 3-position of kaempferol. Component (C) may be derived from raw materials or may be newly added. In addition, the origin of component (C) is not particularly limited as long as it is commonly used in the field of food and beverages, and for example, it may be a chemically synthesized product or one extracted from a plant containing astragalin.
本発明の経口組成物中の成分(C)の含有量は、ボディ感の保持、甘味のキレ改善の観点から、固形分中に0.001質量%以上が好ましく、0.003質量%以上がより好ましく、0.007質量%以上が更に好ましく、またアストラガリン由来の渋味抑制の観点から、固形分中に0.5質量%以下が好ましく、0.3質量%以下がより好ましく、0.1質量%以下が更に好ましい。成分(C)の含有量の範囲としては、本発明の経口組成物の固形分中に、好ましくは0.001~0.5質量%であり、より好ましくは0.003~0.3質量%であり、更に好ましくは0.007~0.1質量%である。なお、成分(C)の含有量は、通常知られている測定法のうち測定試料の状況に適した分析法により測定することが可能であり、例えば、液体クロマトグラフィで分析することが可能である。具体的には、後掲の実施例に記載の方法が挙げられる。なお、測定の際には装置の検出域に適合させるため、試料を凍結乾燥したり、装置の分離能に適合させるため試料中の夾雑物を除去したりする等、必要に応じて適宜処理を施してもよい。 The content of component (C) in the oral composition of the present invention is preferably 0.001% by mass or more, and 0.003% by mass or more in the solid content, from the viewpoint of maintaining the body feeling and improving the sharpness of sweetness. More preferably, it is 0.007% by mass or more, and even more preferably 0.007% by mass or more, and from the viewpoint of suppressing the astringency derived from astragalin, it is preferably 0.5% by mass or less in the solid content, more preferably 0.3% by mass or less, and 0.007% by mass or less. More preferably, it is 1% by mass or less. The content range of component (C) is preferably 0.001 to 0.5% by mass, more preferably 0.003 to 0.3% by mass in the solid content of the oral composition of the present invention. and more preferably 0.007 to 0.1% by mass. Note that the content of component (C) can be measured by an analysis method suitable for the situation of the measurement sample among commonly known measurement methods; for example, it can be analyzed by liquid chromatography. . Specifically, the method described in Examples below may be mentioned. In addition, during measurement, appropriate processing is performed as necessary, such as freeze-drying the sample to match the detection range of the device, or removing impurities from the sample to match the separation capability of the device. It may be applied.
また、本発明の経口組成物は、成分(B)と成分(C)との質量比[(C)/(B)]が0.01~1であるが、ボディ感の保持、甘味のキレ改善の観点から、0.02以上が好ましく、0.03以上がより好ましく、0.04以上が更に好ましく、0.06以上が殊更に好ましく、またアストラガリン由来の渋味抑制の観点から、0.9以下が好ましく、0.7以下がより好ましく、0.5以下が更に好ましい。かかる質量比[(C)/(B)]の範囲としては、好ましくは0.02~0.9であり、より好ましくは0.03~0.7であり、更に好ましくは0.04~0.5であり、0.06~0.5が殊更に好ましい。 In addition, the oral composition of the present invention has a mass ratio [(C)/(B)] of component (B) and component (C) of 0.01 to 1, but maintains the body feeling and maintains the sharpness of sweetness. From the viewpoint of improvement, it is preferably 0.02 or more, more preferably 0.03 or more, even more preferably 0.04 or more, particularly preferably 0.06 or more, and from the viewpoint of suppressing the astringency derived from astragaline, 0 It is preferably .9 or less, more preferably 0.7 or less, and even more preferably 0.5 or less. The range of such mass ratio [(C)/(B)] is preferably 0.02 to 0.9, more preferably 0.03 to 0.7, and even more preferably 0.04 to 0. .5, and 0.06 to 0.5 is particularly preferred.
また、本発明の経口組成物は、必要に応じて許容される担体を含有することができる。例えば、賦形剤(例えば、澱粉、又はデキストリン等の澱粉分解物);結合剤(例えば、プルラン、ゼラチン、ポリビニルピロリドン、ポリビニルアルコール、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルセルロース、メチルセルロース、硬化油等);崩壊剤(例えば、カルメロース、カルメロースカルシウム、クロスカルメロースナトリウム、クロスポピドン、トウモロコシデンプン、低置換度ヒドロキシプロピルセルロース等);滑沢剤(例えば、ステアリン酸カルシウム、ステアリン酸マグネシウム、ショ糖脂肪酸エステル、フマル酸ステアリルナトリウム、タルク、二酸化ケイ素等);嬌味剤(例えば、ステビア等);オリゴ糖、寒天、結晶セルロース、軽質無水ケイ酸、リン酸水素カルシウム、増量剤、界面活性剤、分散剤、緩衝剤、希釈剤等の担体が挙げられる。なお、担体は、経口組成物の種類により適宜選択可能であり、また担体の含有量は、担体の種類に応じて本発明の目的を損なわない範囲内で適宜設定することが可能である。 Moreover, the oral composition of the present invention can contain an acceptable carrier as necessary. For example, excipients (e.g., starch or starch decomposition products such as dextrin); binders (e.g., pullulan, gelatin, polyvinylpyrrolidone, polyvinyl alcohol, hydroxypropyl methylcellulose, hydroxypropylcellulose, methylcellulose, hydrogenated oil, etc.); disintegration agents (e.g., carmellose, carmellose calcium, croscarmellose sodium, crospovidone, corn starch, low-substituted hydroxypropyl cellulose, etc.); lubricants (e.g., calcium stearate, magnesium stearate, sucrose fatty acid ester, fumaric acid) Sodium stearyl, talc, silicon dioxide, etc.); Flavoring agents (e.g. Stevia, etc.); Oligosaccharides, agar, crystalline cellulose, light anhydrous silicic acid, calcium hydrogen phosphate, fillers, surfactants, dispersants, buffers and carriers such as diluents. Note that the carrier can be appropriately selected depending on the type of oral composition, and the content of the carrier can be appropriately set depending on the type of carrier within a range that does not impair the object of the present invention.
更に、本発明の経口組成物は、所望により、酸味料、アミノ酸、たんぱく質、ビタミン、ミネラル、香料、果汁、植物エキス、エステル、色素、乳化剤、乳成分、ココアパウダー、調味料、植物油脂、酸化防止剤、保存料、pH調整剤、品質安定剤、花蜜エキス等の添加剤を1種又は2種以上を含有することができる。添加剤の含有量は、本発明の目的を損なわない範囲内で適宜設定することができる。 Furthermore, the oral composition of the present invention may optionally contain acidulants, amino acids, proteins, vitamins, minerals, fragrances, fruit juices, plant extracts, esters, pigments, emulsifiers, milk components, cocoa powder, seasonings, vegetable oils, and oxidized It may contain one or more additives such as inhibitors, preservatives, pH adjusters, quality stabilizers, and nectar extract. The content of the additive can be appropriately set within a range that does not impair the purpose of the present invention.
本発明の経口組成物としては、飲食品が好ましい。飲食品の具体例としては、例えば、インスタント飲料;濃縮還元飲料;乳飲料、ヨーグルト、チーズ等の乳製品;ゼリー、チョコレート、キャンディー、スナック、ビスケット、米菓等の菓子の飲食品が挙げられ、健康食品(栄養機能食品、特定保健用食品、栄養補助食品、健康補助食品、サプリメント等)とすることもできる。なお、インスタント飲料又は濃縮還元飲料とは、液体に希釈溶解して飲料として飲用に供されるものをいい、液体は飲料に還元できれば特に限定されない。例えば、水、炭酸水、牛乳、豆乳等が挙げられ、液体の温度は問わない。また、固形食品、健康食品である場合の剤型としては、例えば、顆粒剤、錠剤、カプセル剤、散剤、丸剤、チュアブル剤、トローチ剤等が挙げられる。中でも、経口組成物としては、固形経口組成物が好ましく、固形食品が更に好ましい。 The oral composition of the present invention is preferably a food or drink. Specific examples of foods and beverages include instant beverages; concentrated beverages; dairy products such as milk drinks, yogurt, and cheese; confectionery foods and beverages such as jelly, chocolate, candy, snacks, biscuits, and rice crackers; It can also be a health food (food with nutritional function claims, food for specified health uses, nutritional supplements, health supplements, supplements, etc.). Incidentally, an instant beverage or a concentrated and reduced beverage refers to a beverage that is diluted and dissolved in a liquid to be consumed as a beverage, and the liquid is not particularly limited as long as it can be reduced to a beverage. Examples include water, carbonated water, milk, soy milk, etc., and the temperature of the liquid does not matter. In addition, examples of dosage forms for solid foods and health foods include granules, tablets, capsules, powders, pills, chewables, and troches. Among these, as the oral composition, solid oral compositions are preferred, and solid foods are more preferred.
本発明の経口組成物は、常法にしたがって製造することが可能であり、適宜の方法を採り得る。例えば、成分(A)、成分(B)及び成分(C)、必要により他の成分を配合し、成分(A)及び成分(B)の各含有量、並びに質量比[(C)/(B)]が上記範囲内となるように混合して製造することができる。成分(A)、成分(B)及び成分(C)の混合順序は特に限定されず、任意の順序で添加しても、3者を同時に添加してもよい。混合方法としては、撹拌、震盪等の適宜の方法を採用することが可能であり、混合装置を使用しても構わない。混合装置の混合方式は、容器回転型でも、容器固定型でもよい。容器回転型として、例えば、水平円筒型、V型、ダブルコーン型、立方体型等を採用することができる。また、容器固定型として、例えば、リボン型、スクリュー型、円錐形スクリュー型、パドル型、流動層型、フィリップスブレンダ-等を採用することができる。また、公知の造粒法により造粒物としてもよい。造粒方法としては、例えば、噴霧造粒、流動層造粒、圧縮造粒、転動造粒、撹拌造粒、押出造粒、粉末被覆造粒等が挙げられる。なお、造粒条件は、造粒方法により適宜選択することができる。また、錠剤とする場合には、湿式打錠及び乾式打錠のいずれでもよく、公知の圧縮成形機を使用することができる。更に、濃縮液状である場合、例えば、常圧にて溶媒の蒸発を行う常圧濃縮法、減圧にて溶媒の蒸発を行う減圧濃縮法、膜分離により溶媒を除去する膜濃縮法等の公知の濃縮方法を採用することができる。 The oral composition of the present invention can be manufactured according to a conventional method, and an appropriate method can be used. For example, by blending component (A), component (B), and component (C), and other components as necessary, the respective contents of component (A) and component (B), and the mass ratio [(C)/(B )] is within the above range. The mixing order of component (A), component (B), and component (C) is not particularly limited, and they may be added in any order, or the three may be added at the same time. As a mixing method, it is possible to employ an appropriate method such as stirring or shaking, and a mixing device may also be used. The mixing method of the mixing device may be a container rotating type or a container fixed type. As the container rotation type, for example, a horizontal cylindrical type, a V type, a double cone type, a cubic type, etc. can be adopted. Further, as the container fixed type, for example, a ribbon type, screw type, conical screw type, paddle type, fluidized bed type, Phillips blender, etc. can be adopted. Alternatively, it may be made into a granulated product using a known granulation method. Examples of the granulation method include spray granulation, fluidized bed granulation, compression granulation, rolling granulation, stirring granulation, extrusion granulation, powder coating granulation, and the like. Note that the granulation conditions can be appropriately selected depending on the granulation method. In addition, when forming tablets, either wet tabletting or dry tableting may be used, and a known compression molding machine may be used. Furthermore, in the case of a concentrated liquid, known methods such as the normal pressure concentration method in which the solvent is evaporated at normal pressure, the vacuum concentration method in which the solvent is evaporated under reduced pressure, and the membrane concentration method in which the solvent is removed by membrane separation, etc. Concentration methods can be employed.
1.糖アルコールの分析
糖アルコールの分析は、HPLC(高速液体クロマトグラフィ)法により、次に示す方法にしたがって行った。
分析機器の装置構成は次の通りである。
・検出器 :示差屈折計 RID-10A(島津製作所社製)
・カラム :Shodex Asahipak NH2P-50 4E、φ4.6mm×250mm(昭和電工社製)
1. Analysis of Sugar Alcohol Analysis of sugar alcohol was performed by HPLC (high performance liquid chromatography) according to the method shown below.
The configuration of the analytical equipment is as follows.
・Detector: Differential refractometer RID-10A (manufactured by Shimadzu Corporation)
・Column: Shodex Asahipak NH2P-50 4E, φ4.6mm x 250mm (manufactured by Showa Denko)
分析条件は次の通りである。
・カラム温度:室温
・移動相 :アセトニトリル及び水の混液(81:19 体積比)
・流量 :1mL/min
・試料注入量:20μL
The analysis conditions are as follows.
・Column temperature: Room temperature ・Mobile phase: Mixture of acetonitrile and water (81:19 volume ratio)
・Flow rate: 1mL/min
・Sample injection amount: 20μL
以下の手順にて分析用試料を調製した。
試料を3g量りとり、これに水10mLを加えて溶解し中和した溶液を、超音波洗浄器を用いて超音波抽出を30分間行った。その溶液に水を加えて20mLに定容した。その溶液をメンブレンフィルターでろ過し、試料溶液とした。その試料溶液を高速液体クロマトグラフィ分析に供した。
A sample for analysis was prepared according to the following procedure.
3 g of the sample was weighed out, and 10 mL of water was added to dissolve and neutralize the sample. The solution was subjected to ultrasonic extraction for 30 minutes using an ultrasonic cleaner. Water was added to the solution to adjust the volume to 20 mL. The solution was filtered through a membrane filter to obtain a sample solution. The sample solution was subjected to high performance liquid chromatography analysis.
2.二糖の分析
二糖の含有量はHPLC分析法などの公知の方法で求めることができる。具体的には下記の方法で求めることができる。分析機器はHPLCを使用する。装置の構成ユニットの型番、分析条件は次の通りである。
・機種 :LC-10ADvp(島津製作所社製)
・検出器 :蛍光分光光度計 RF-10AXL(島津製作所社製)
・カラム :TSKgel SUGAR AXIφ4.6×150mm(東ソー社製)
・カラム温度 :60℃
・移動相 :0.5mol/Lホウ酸緩衝液(pH8.7)
・サンプル注入量:20μL
・流量 :0.4mL/min
・蛍光励起波長:320nm
・蛍光測定波長:430nm
・ポストカラム:反応液 ;1W/V%のL-アルギニン溶液
反応液流量;0.7mL/min
反応温度 ;150℃
2. Disaccharide Analysis The disaccharide content can be determined by a known method such as HPLC analysis. Specifically, it can be determined by the following method. Analytical equipment uses HPLC. The model numbers and analysis conditions of the constituent units of the apparatus are as follows.
・Model: LC-10ADvp (manufactured by Shimadzu Corporation)
・Detector: Fluorescence spectrophotometer RF-10AXL (manufactured by Shimadzu Corporation)
・Column: TSKgel SUGAR AXIφ4.6×150mm (manufactured by Tosoh Corporation)
・Column temperature: 60℃
・Mobile phase: 0.5 mol/L borate buffer (pH 8.7)
・Sample injection volume: 20μL
・Flow rate: 0.4mL/min
・Fluorescence excitation wavelength: 320nm
・Fluorescence measurement wavelength: 430nm
・Post column: Reaction solution; 1W/V% L-arginine solution
Reaction liquid flow rate: 0.7mL/min
Reaction temperature: 150℃
試料2gを精秤し、中和して濃縮乾固させた後、水で再溶解させ、水で50mLに定容する。これをSep-Pak plus Accell QMA(日本ウォーターズ社製)に通液し、更に孔径0.45μmのメンブレンフィルターで濾過した溶液について、高速液体クロマトグラフ法により分析する。 After accurately weighing 2 g of the sample, neutralizing it and concentrating it to dryness, it is redissolved in water, and the volume is adjusted to 50 mL with water. This solution is passed through Sep-Pak plus Accell QMA (manufactured by Nippon Waters), filtered through a membrane filter with a pore size of 0.45 μm, and the solution is analyzed by high performance liquid chromatography.
3.カフェインの分析
試料溶液をフィルター(0.45μm)で濾過し、高速液体クロマトグラフィ(型式SCL-10AVP)を用い、オクタデシル基導入液体クロマトグラフィ用パックドカラム(L-カラムTM ODS、4.6mmφ×250mm:財団法人 化学物質評価研究機構製)を装着し、カラム温度35℃でグラジエント法により測定した。移動相A液は酢酸を0.1mol/L含有する蒸留水溶液、B液は酢酸を0.1mol/L含有するアセトニトリル溶液とし、流速は1mL/分、試料注入量は10μL、UV検出器波長は280nmの条件で行った。グラジエント条件は以下の通りである。リテンションタイム条件は、カフェインの標準試薬を用いて設定した。
3. Analysis of caffeine The sample solution was filtered with a filter (0.45 μm), and using high performance liquid chromatography (model SCL-10AVP), an octadecyl group-introduced packed column for liquid chromatography (L-column TM ODS, 4.6 mmφ x 250 mm: (manufactured by the Japan Chemical Evaluation and Research Institute) was installed, and the measurement was carried out using the gradient method at a column temperature of 35°C. Mobile phase A solution was a distilled aqueous solution containing 0.1 mol/L of acetic acid, B solution was an acetonitrile solution containing 0.1 mol/L of acetic acid, the flow rate was 1 mL/min, the sample injection amount was 10 μL, and the UV detector wavelength was The experiment was carried out under the condition of 280 nm. The gradient conditions are as follows. Retention time conditions were established using a standard reagent for caffeine.
濃度勾配条件
時間(分) A液濃度(体積%) B液濃度(体積%)
0 97% 3%
5 97% 3%
37 80% 20%
43 80% 20%
43.5 0% 100%
48.5 0% 100%
49 97% 3%
60 97% 3%
Concentration gradient conditions Time (minutes) Concentration of liquid A (% by volume) Concentration of liquid B (% by volume)
0 97% 3%
5 97% 3%
37 80% 20%
43 80% 20%
43.5 0% 100%
48.5 0% 100%
49 97% 3%
60 97% 3%
4.アストラガリンの分析
試料溶液をフィルター(0.45μm)で濾過し、高速液体クロマトグラフィ(型式LC-20 Prominence,島津製作所製)を用い、カラム〔Cadenza CD-C18(3μm,4.6mmφ×150mm,Imtakt)〕を装着し、カラム温度40℃にてグラジエント法により行った。移動相C液は酢酸を0.05質量%含有するアセトニトリル溶液、D液はアセトニトリル溶液とし、流速は1mL/分、試料注入量は10μL、UV検出器波長は360nmの条件で行った。なお、グラジエントの条件は、以下のとおりである。
4. Analysis of Astragalin The sample solution was filtered with a filter (0.45 μm), and a column [Cadenza CD-C18 (3 μm, 4.6 mmφ×150 mm, Imtakt )] was installed, and the gradient method was used at a column temperature of 40°C. The mobile phase C solution was an acetonitrile solution containing 0.05% by mass of acetic acid, and the D solution was an acetonitrile solution. The flow rate was 1 mL/min, the sample injection amount was 10 μL, and the UV detector wavelength was 360 nm. Note that the gradient conditions are as follows.
濃度勾配条件
時間(分) C液濃度(体積%) D液濃度(体積%)
0 85% 15%
20 80% 20%
35 10% 90%
50 10% 90%
50.1 85% 15%
60 85% 15%
Concentration gradient conditions Time (minutes) Concentration of C solution (volume%) Concentration of D solution (volume%)
0 85% 15%
20 80% 20%
35 10% 90%
50 10% 90%
50.1 85% 15%
60 85% 15%
アストラガリンの標準品を用いて濃度既知の標準溶液を調製し、上記分析条件にて高速液体クロマトグラフィ分析に供することによりリテンションタイムを測定するとともに、検量線を作成した。
・アストラガリン :18.2分
上記リテンションタイムで一致したピークをアストラガリンとして試料溶液中の各成分の定量を行った。
A standard solution of known concentration was prepared using a standard product of astragalin, and the retention time was measured by subjecting it to high performance liquid chromatography analysis under the above analysis conditions, and a calibration curve was created.
- Astragaline: 18.2 minutes Each component in the sample solution was quantified using the peak that coincided with the above retention time as Astragaline.
実施例1~3、比較例1及び参考例1
表3に示す各成分を均一に混合して粉末食品を製造した。得られた粉末食品について分析及び官能評価を行った。なお、官能評価は、下記の官能評価1に準じて行った。その結果を表3に併せて示す。
Examples 1 to 3, Comparative Example 1 and Reference Example 1
Each component shown in Table 3 was mixed uniformly to produce a powdered food. Analysis and sensory evaluation were performed on the obtained powdered food. In addition, the sensory evaluation was performed according to the following sensory evaluation 1. The results are also shown in Table 3.
官能評価1
(1)ボディ感の評価基準
カフェイン含有量が異なる、下記の表1に示す標準粉末食品を調製した。そして、専門パネル4名が表1に示す標準粉末食品のボディ感について、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準粉末食品0.2gをカフェインが低濃度のものから順に喫食し、ボディ感の強さを記憶した。次いで、各専門パネルが各被験粉末食品0.2gを喫食し、ボディ感の程度を認識し、標準粉末食品の中からボディ感が最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
Sensory evaluation 1
(1) Evaluation criteria for body feel Standard powder foods shown in Table 1 below with different caffeine contents were prepared. Then, four expert panelists agreed to use the evaluation criteria shown in Table 1 regarding the body feel of the standard powdered foods shown in Table 1, and conducted a sensory test using the following procedure. First, each expert panel ate 0.2 g of standard powdered foods in order of decreasing caffeine concentration and memorized the strength of the body sensation. Next, each expert panel ate 0.2 g of each test powder food, recognized the degree of body sensation, and determined which of the standard powder foods had the closest body sensation. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
(2)甘味のキレの評価基準
カフェイン含有量が異なる、下記の表2に示す標準粉末食品を調製した。そして、専門パネル4名が表2に示す標準粉末食品の甘味のキレについて、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準粉末食品0.2gをカフェインが低濃度のものから順に喫食し、甘味のキレの程度を記憶した。次いで、各専門パネルが各被験粉末食品0.2gを喫食し、甘味のキレの程度を認識し、標準粉末食品の中から甘味のキレが最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
(2) Evaluation criteria for sweetness sharpness Standard powdered foods shown in Table 2 below with different caffeine contents were prepared. Then, the four expert panelists agreed to use the evaluation criteria shown in Table 2 regarding the sharpness of sweetness of the standard powdered foods shown in Table 2, and conducted a sensory test using the following procedure. First, each expert panel ate 0.2 g of standard powdered foods in order of decreasing caffeine concentration and memorized the level of sweetness. Next, each expert panel ate 0.2 g of each test powdered food, recognized the degree of sharpness of sweetness, and determined which standard powdered food had the closest sharpness of sweetness. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
実施例4~9及び比較例2~4
表4に示す各成分を均一に混合したこと以外は、実施例1と同様の操作により粉末食品を製造した。得られた粉末食品について分析及び官能評価を行った。なお、官能評価は、官能評価1に準じて行った。その結果を、参考例1の結果とともに表4に併せて示す。
Examples 4 to 9 and Comparative Examples 2 to 4
A powdered food was produced in the same manner as in Example 1, except that the components shown in Table 4 were mixed uniformly. Analysis and sensory evaluation were performed on the obtained powdered food. In addition, the sensory evaluation was performed according to the sensory evaluation 1. The results are shown in Table 4 together with the results of Reference Example 1.
実施例10、11、比較例5、6及び参考例2、3
表5に示す各成分を均一に混合したこと以外は、実施例1と同様の操作により粉末食品を製造した。得られた粉末食品について分析及び官能評価を行った。なお、官能評価は、官能評価1に準じて行った。その結果を、実施例2、比較例1及び参考例1の結果とともに表5に併せて示す。
Examples 10 and 11, Comparative Examples 5 and 6, and Reference Examples 2 and 3
A powdered food was produced in the same manner as in Example 1, except that the components shown in Table 5 were mixed uniformly. Analysis and sensory evaluation were performed on the obtained powdered food. In addition, the sensory evaluation was performed according to the sensory evaluation 1. The results are shown in Table 5 together with the results of Example 2, Comparative Example 1, and Reference Example 1.
実施例12~17及び比較例7~14
表6に示す各成分を均一に混合したこと以外は、実施例1と同様の操作により粉末食品を製造した。得られた粉末食品ついて分析及び官能評価を行った。なお、官能評価は、官能評価1に準じて行った。その結果を表6に併せて示す。
Examples 12 to 17 and Comparative Examples 7 to 14
A powdered food was produced in the same manner as in Example 1, except that the components shown in Table 6 were mixed uniformly. Analysis and sensory evaluation were performed on the obtained powdered food. In addition, the sensory evaluation was performed according to the sensory evaluation 1. The results are also shown in Table 6.
実施例18及び比較例15
表9に示す各成分を均一に混合して粉末状のインスタント飲料を得た。次いで、得られた粉末状のインスタント飲料1質量部に対し全体で8質量部になるように25℃の温水で希釈し、還元飲料を得た。得られたインスタント飲料について分析を行い、還元飲料について官能評価を行った。なお、官能評価は、下記の官能評価2に準じて行った。その結果を表9に併せて示す。
Example 18 and Comparative Example 15
Each component shown in Table 9 was mixed uniformly to obtain a powdered instant beverage. Next, 1 part by mass of the obtained powdered instant beverage was diluted with 25° C. warm water to a total of 8 parts by mass to obtain a reduced beverage. The obtained instant beverage was analyzed, and the reduced beverage was subjected to sensory evaluation. In addition, the sensory evaluation was performed according to the following sensory evaluation 2. The results are also shown in Table 9.
官能評価2
(1)ボディ感の評価基準
カフェイン含有量が異なる、下記の表7に示す標準インスタント飲料を調製した。次いで、得られた標準インスタント飲料1質量部に対し全体で8質量部になるように25℃の温水で希釈し、還元飲料を得た。そして、専門パネル4名が表7に示す標準インスタント飲料から調製した還元飲料のボディ感について、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが、カフェインが低濃度の還元飲料から順に飲用し、ボディ感の強さを記憶した。次いで、各専門パネルが各被験還元飲料を飲用し、ボディ感の程度を認識し、標準インスタント飲料から調製した還元飲料の中からボディ感が最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
Sensory evaluation 2
(1) Evaluation criteria for body feel Standard instant drinks shown in Table 7 below with different caffeine contents were prepared. Next, 1 part by mass of the obtained standard instant beverage was diluted with 25° C. warm water to a total of 8 parts by mass to obtain a reduced beverage. Then, four expert panelists agreed to use the evaluation criteria shown in Table 7 regarding the body feel of reduced drinks prepared from the standard instant drinks shown in Table 7, and conducted a sensory test according to the following procedure. First, each expert panel drank reduced caffeine drinks in order, starting with the lowest concentration of caffeine, and memorized the strength of the body sensation. Next, each expert panel drank each test reduced beverage, recognized the degree of body feel, and determined the one with the closest body feeling among the reduced drinks prepared from standard instant drinks. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
(2)甘味のキレの評価基準
カフェイン含有量が異なる、下記の表8に示す標準インスタント飲料を調製した。次いで、得られた標準インスタント飲料1質量部に対し全体で8質量部になるように25℃の温水で希釈し、還元飲料を得た。そして、専門パネル4名が表8に示す標準インスタント飲料から調製した還元飲料の甘味のキレについて、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが、カフェインが低濃度の還元飲料から順に飲用し、甘味のキレの程度を記憶した。次いで、各専門パネルが各被験還元飲料を飲用し、甘味のキレの程度を認識し、標準インスタント飲料から調製した還元飲料の中から甘味のキレが最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
(2) Evaluation criteria for sharpness of sweetness Standard instant drinks shown in Table 8 below with different caffeine contents were prepared. Next, 1 part by mass of the obtained standard instant beverage was diluted with 25° C. warm water to a total of 8 parts by mass to obtain a reduced beverage. Then, four expert panelists agreed to use the evaluation criteria shown in Table 8 regarding the sharpness of sweetness of reduced drinks prepared from the standard instant drinks shown in Table 8, and conducted a sensory test using the following procedure. First, each expert panel drank reduced caffeine drinks in order, starting with the lowest concentration of caffeine, and memorized the level of sharpness of the sweetness. Next, each expert panel drank each test reduced drink, recognized the degree of sharpness of sweetness, and decided which reduced drink had the sharpest sweetness closest to that of the reduced drinks prepared from standard instant drinks. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
実施例19及び比較例16
表12に示す各成分を混合し、合計で100質量%になるよう水を加え、90℃まで加熱して撹拌しながら溶解したのち、型に流し入れ、5℃に冷蔵してグミを得た。そして、得られたグミについて官能評価と分析を行った。なお、官能評価は、下記の官能評価3に準じて行った。その結果を表12に示す。
Example 19 and Comparative Example 16
Each component shown in Table 12 was mixed, water was added to make a total of 100% by mass, the mixture was heated to 90°C and dissolved with stirring, then poured into a mold and refrigerated at 5°C to obtain a gummy. Then, sensory evaluation and analysis were performed on the obtained gummies. In addition, the sensory evaluation was performed according to the following sensory evaluation 3. The results are shown in Table 12.
官能評価3
(1)ボディ感の評価基準
カフェイン含有量が異なる、下記の表10に示す標準グミを調製した。そして、専門パネル4名が表10に示す標準グミのボディ感について、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準グミ3gを、カフェインが低濃度のものから順に喫食し、ボディ感の強さを記憶した。次いで、各専門パネルが各被験グミ3gを喫食し、ボディ感の程度を認識し、標準グミの中からボディ感が最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
Sensory evaluation 3
(1) Evaluation criteria for body feel Standard gummies shown in Table 10 below with different caffeine contents were prepared. Then, the four expert panels agreed to use the evaluation criteria shown in Table 10 regarding the body feel of the standard gummy, and conducted a sensory test using the following procedure. First, each panel of experts ate 3g of standard gummies, starting with the one with the lowest concentration of caffeine, and memorized the strength of the body sensation. Next, each expert panel ate 3 g of each test gummy, recognized the degree of body feel, and determined which gummy had the closest body feel to the standard gummy. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
(2)甘味のキレの評価基準
カフェイン含有量が異なる、下記の表11に示す標準グミを調製した。そして、専門パネル4名が表11に示す標準グミの甘味のキレについて、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準グミ3gをカフェインが低濃度のものから順に喫食し、甘味のキレの程度を記憶した。次いで、各専門パネルが各被験グミ3gを喫食し、甘味のキレの程度を認識し、標準グミの中から甘味のキレが最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
(2) Evaluation criteria for sharpness of sweetness Standard gummies shown in Table 11 below with different caffeine contents were prepared. Then, the four expert panelists agreed to use the evaluation criteria shown in Table 11 regarding the sharpness of sweetness of the standard gummies shown in Table 11, and conducted a sensory test using the following procedure. First, each panel of experts ate 3 g of standard gummies, starting with the one with the lowest concentration of caffeine, and memorized the level of sharpness of the sweetness. Next, each expert panel ate 3 g of each test gummy, recognized the degree of sharpness of sweetness, and decided which standard gummy had the closest sharpness of sweetness. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
実施例20及び比較例17
表15に示す各成分を混合し、合計で100質量%になるよう水を加え、90℃まで加熱して撹拌しながら溶解したのち、型に流し入れ、5℃に冷蔵してゼリー食品を得た。そして、得られたゼリー食品について官能評価と分析を行った。なお、官能評価は、下記の官能評価4に準じて行った。その結果を表15に示す。
Example 20 and Comparative Example 17
Each component shown in Table 15 was mixed, water was added to make a total of 100% by mass, the mixture was heated to 90°C and dissolved with stirring, then poured into a mold and refrigerated at 5°C to obtain a jelly food. . Then, the obtained jelly food was subjected to sensory evaluation and analysis. In addition, the sensory evaluation was performed according to the following sensory evaluation 4. The results are shown in Table 15.
官能評価4
(1)ボディ感の評価基準
カフェイン含有量が異なる、下記の表13に示す標準ゼリー食品を調製した。そして、専門パネル4名が表13に示す標準ゼリー食品のボディ感について、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準ゼリー食品7gをカフェインが低濃度のものから順に喫食し、ボディ感の強さを記憶した。次いで、各専門パネルが各被験ゼリー食品7gを喫食し、ボディ感の程度を認識し、標準ゼリー食品の中からボディ感が最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
Sensory evaluation 4
(1) Evaluation criteria for body feel Standard jelly foods shown in Table 13 below with different caffeine contents were prepared. Then, four expert panelists agreed to use the evaluation criteria shown in Table 13 regarding the body feel of the standard jelly foods shown in Table 13, and conducted a sensory test according to the following procedure. First, each expert panel ate 7 g of standard jelly foods in order of decreasing caffeine concentration and memorized the strength of the body sensation. Next, each expert panel ate 7 g of each test jelly food, recognized the degree of body feel, and determined the one with the closest body feel from among the standard jelly foods. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
(2)甘味のキレの評価基準
カフェイン含有量が異なる、下記の表14に示す標準ゼリー食品を調製した。そして、専門パネル4名が表14に示す標準ゼリー食品の甘味のキレについて、同表に示す評価基準とすることを合意したうえで、次の手順で官能試験を行った。先ず、各専門パネルが標準ゼリー食品7gをカフェインが低濃度のものから順に喫食し、甘味のキレの程度を記憶した。次いで、各専門パネルが各被験グミ3gを喫食し、甘味のキレの程度を認識し、標準ゼリー食品の中から甘味のキレが最も近いものを決定した。そして、各専門パネルが決定した評点に基づいて、協議により「0.5」刻みで最終評点を決定した。
(2) Evaluation criteria for sharpness of sweetness Standard jelly foods shown in Table 14 below with different caffeine contents were prepared. Then, four expert panelists agreed to use the evaluation criteria shown in Table 14 regarding the sharpness of sweetness of the standard jelly foods shown in Table 14, and conducted a sensory test using the following procedure. First, each expert panel ate 7 g of standard jelly foods in order of decreasing caffeine concentration and memorized the level of sweetness. Next, each expert panel ate 3 g of each test gummy, recognized the degree of sharpness of sweetness, and decided which standard jelly food had the sharpest sweetness. Based on the scores determined by each expert panel, final scores were determined in 0.5 increments through discussion.
表3~6、9、12及び15から、カフェインを含有する飲食品に糖アルコール及び/又は二糖を含有させると、ボディ感が低下するだけでなく、甘味のキレも悪化するが、カフェインに対してアストラガリンを特定の量比で含有させることで、糖アルコール及び/又は二糖と、カフェインを含有しながらも、ボディ感が保たれ、甘味のキレの良好な飲食品が得られることがわかる。 Tables 3 to 6, 9, 12, and 15 show that when sugar alcohols and/or disaccharides are added to foods and beverages containing caffeine, not only does the body feel lower, but the sharpness of sweetness also worsens; By containing astragalin in a specific ratio of sugar alcohol and/or disaccharide and caffeine, it is possible to obtain food and drink products that maintain body and have a sharp sweetness, even though they contain sugar alcohols and/or disaccharides and caffeine. I know that it will happen.
Claims (3)
次の成分(A)、(B)及び(C);
(A)糖アルコール及び二糖から選択される少なくとも1種
固形分中に20~95質量%
(B)カフェイン 固形分中に0.01~1.0質量%、及び
(C)アストラガリン
を含有し、
成分(B)と成分(C)との質量比[(C)/(B)]が0.01~1である、
経口組成物。
The following ingredients (A), (B) and (C);
(A) At least one selected from sugar alcohols and disaccharides
20-95% by mass in solid content
(B) Contains 0.01 to 1.0% by mass of caffeine in solid content, and (C) Astragalin,
The mass ratio [(C)/(B)] of component (B) and component (C) is 0.01 to 1;
Oral composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018225763 | 2018-11-30 | ||
JP2018225763 | 2018-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020092699A JP2020092699A (en) | 2020-06-18 |
JP7366711B2 true JP7366711B2 (en) | 2023-10-23 |
Family
ID=71084219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019213511A Active JP7366711B2 (en) | 2018-11-30 | 2019-11-26 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7366711B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002291441A (en) | 2001-03-30 | 2002-10-08 | Sunstar Inc | Astragalin-containing food |
JP2007159431A (en) | 2005-12-12 | 2007-06-28 | Kao Corp | Packaged liquid seasoning |
JP2010131008A (en) | 2008-11-10 | 2010-06-17 | Kao Corp | Purified tea extract |
JP6335362B2 (en) | 2017-05-25 | 2018-05-30 | ヒロセ電機株式会社 | Electrical connector assembly |
-
2019
- 2019-11-26 JP JP2019213511A patent/JP7366711B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002291441A (en) | 2001-03-30 | 2002-10-08 | Sunstar Inc | Astragalin-containing food |
JP2007159431A (en) | 2005-12-12 | 2007-06-28 | Kao Corp | Packaged liquid seasoning |
JP2010131008A (en) | 2008-11-10 | 2010-06-17 | Kao Corp | Purified tea extract |
JP6335362B2 (en) | 2017-05-25 | 2018-05-30 | ヒロセ電機株式会社 | Electrical connector assembly |
Also Published As
Publication number | Publication date |
---|---|
JP2020092699A (en) | 2020-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5207611B2 (en) | Saccharification inhibitor | |
JP6795539B2 (en) | Food composition | |
WO2018230032A1 (en) | Chlorogenic acid-containing composition | |
WO2014103415A1 (en) | Cacao composition reduced in caffeine content | |
JP7371147B2 (en) | Oral composition | |
JP7366711B2 (en) | Oral composition | |
JP6782737B2 (en) | Oral composition | |
JP2007230881A (en) | Anti-fatigue composition | |
JP6782738B2 (en) | Oral composition | |
JP2018085964A (en) | Solid composition | |
JP2018174758A (en) | Astringent taste inhibitor | |
JP7325971B2 (en) | solid oral composition | |
JP7474900B2 (en) | Oral Compositions | |
JP7033021B2 (en) | Oral composition | |
JP7321743B2 (en) | solid composition | |
JP2023045555A (en) | oral composition | |
JPH04148654A (en) | Honey-containing powder and its production | |
JP7469549B2 (en) | Oral Compositions | |
KR101498724B1 (en) | Polygalatenuifolia willdenow extract with enhanced acetylcholinesterase inhibition effect and product containing thereof for preventing or improving the memory capability | |
JP7349326B2 (en) | Oral composition | |
JP2024053551A (en) | Oral Compositions | |
JP2022076231A (en) | Oral composition | |
JP2006290856A (en) | Prophylactic agent for colon-cancer | |
JP2022174474A (en) | solid composition | |
TW202237142A (en) | solid composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220921 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231003 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231011 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 7366711 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |